Skip to content
Riboway Therapeutics: Resilience, RNA, and redefining the undruggable
At this year’s BIO International Convention in Boston, Riboway Therapeutics emerged as the winner ...
Read More
Startup Stadium: Tezcat Biosciences targets common cancer mutation
A Rat sarcoma (RAS) mutation is an oncogene, a gene that causes cancer ...
Read More
Psoriasis awareness: The condition is more than skin deep
Over 8 million people in the U.S., and 125 million worldwide, live with ...
Read More
BIO 2025: As M&A slows, biotechs need to show good data
M&A in biotech has slowed from its peak in 2023 but there are ...
Read More
BIO 2025: How weight loss drugs are disrupting chronic disease
“Initial weight loss is just the first chapter,” said Mia de Graaf, Deputy ...
Read More
BIO 2025: Psychedelics go mainstream – what’s next?
When experts discussed clinical uses of psychedelics two years ago at the 2023 ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
BIO Events
Riboway Therapeutics: Resilience, RNA, and redefining the undruggable
At this year’s BIO International Convention in Boston, Riboway Therapeutics emerged as the winner of the 2025 BIO Start-Up Stadium seed-stage category. For founder and CEO ...
BIO Events
Startup Stadium: Tezcat Biosciences targets common cancer mutation
A Rat sarcoma (RAS) mutation is an oncogene, a gene that causes cancer when mutated. The RAS is the most commonly mutated oncogene in human ...
Federal Policy
Psoriasis awareness: The condition is more than skin deep
Over 8 million people in the U.S., and 125 million worldwide, live with psoriasis—about 2–3% of the population. Far from being a simple cosmetic condition, ...
Health
BIO 2025: As M&A slows, biotechs need to show good data
M&A in biotech has slowed from its peak in 2023 but there are still deals to be done, especially for companies who can present good ...
BIO Events
BIO 2025: How weight loss drugs are disrupting chronic disease
“Initial weight loss is just the first chapter,” said Mia de Graaf, Deputy Executive Health Editor at Business Insider, “but the real challenge and opportunity ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
Life sciences job report shows growth slowing, but firms still invest in talent
As the United States has long been a life sciences leader, the health of the life sciences sector is a ...
Read More
International
Bio's View
Emerging biotechs get bearish to weather market trends, finds BIO report
“Small companies are the lifeblood of the industry and a lot of what they do, and what they’re experiencing, greatly ...
Read More
